Intrinsic Therapeutics’ Barricaid gets increased reimbursement for ASCs

CMS’ 2025 Final Rule included an increased payment for Intrinsic Therapeutics’ Barricaid device, according to a Nov. 12 news release.

Advertisement

The HCPCS procedure code C9757, created for lumbar discectomy with repair of annular defect using the Barricaid device received an increased payment from $6,500.62 to $9,527.15 in ASCs. 

Barriciad earned a Category 1 CPT code from the American Medical Association in October. It has been used in more than 11,000 patients. It is designed to prevent regeneration and reoperation in lumbar discectomy patients with large annular defects.

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.